Showing results (3671-3680 of 6,511) with videos related to
Sort By:
Pageof 652
Experimental Hematology|February 1, 1986
Expression of CD11, CDw15, and transferrin receptor antigens on human hematopoietic progenitor cellsJ H Falkenburg, F Koning, N Duinkerken, et al.Experimental Hematology|May 16, 2017
With me or against me: Tumor suppressor and drug resistance activities of SAMHD1Nikolas Herold, Sean G Rudd, Kumar Sanjiv, et al.Experimental Hematology|May 9, 2017
Development of an assay for cellular efflux of pharmaceutically active agents and its relevance to understanding drug interactionsBenigno C Valdez, Moustapha Hassan, Borje S AnderssonExperimental Hematology|May 9, 2017
CBP/Catenin antagonists: Targeting LSCs' Achilles heelYong-Mi Kim, Eun-Ji Gang, Michael KahnExperimental Hematology|September 28, 2016
AC220 and AraC cause differential inhibitory dynamics in patient-derived M5-AML with FLT3-ITD and, thus, ultimately distinct therapeutic outcomesXiaoyu An, Jinping Liu, Na Wang, et al.Experimental Hematology|October 1, 1988
Down-modulation of high-affinity receptors for erythropoietin on murine erythroblasts by interleukin 3J K Fraser, J Nicholls, C Coffey, et al.Experimental Hematology|October 1, 1988
Activation of multiple hemopoietic growth factor genes in Abelson virus-transformed myeloid cellsR K Humphries, S Abraham, G Krystal, et al.Experimental Hematology|September 14, 2016
MicroRNA-155 is upregulated in MLL-rearranged AML but its absence does not affect leukemia developmentEdith Schneider, Anna Staffas, Linda Röhner, et al.Experimental Hematology|May 22, 2017
HIF-1α-stabilizing agent FG-4497 rescues human CD34+ cell mobilization in response to G-CSF in immunodeficient miceBianca Nowlan, Kathryn Futrega, Marion E Brunck, et al.Experimental Hematology|May 1, 2017
Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft modelsMarco Carretta, Bauke de Boer, Jenny Jaques, et al.Pageof 652